XML 47 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Series A-1 Convertible Preferred Stock
Series A-2 Convertible Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Temporary Equity Beginning Balance at Dec. 31, 2021   $ 8,454 $ 44,639 $ 112,083        
Temporary Equity Beginning Balance, shares at Dec. 31, 2021   1,372,970 3,939,069 7,234,766        
Beginning Balance at Dec. 31, 2021 $ (32,082)         $ 1,653 $ 17 $ (33,752)
Beginning Balance, shares at Dec. 31, 2021         963,588      
Temporary equity, Issuance of Series A-2 stock upon exercise of warrants, shares     35,529          
Temporary equity, Issuance of Series A-2 stock upon exercise of warrants     $ 574          
Temporary equity, Conversion of convertible preferred stock upon IPO, shares   (1,372,970) (3,974,598) (7,234,766)        
Temporary equity, Conversion of convertible preferred stock upon IPO   $ (8,454) $ (45,213) $ (112,083)        
Conversion of convertible preferred stock upon IPO, shares         12,359,856      
Conversion of convertible preferred stock upon IPO 165,752       $ 1 165,751    
Issuance of Common Stock in IPO, net of underwriters' fees and issuance costs, shares         10,238,951      
Issuance of Common Stock in IPO, net of underwriters' fees and issuance costs 110,183       $ 1 110,182    
Release of common stock from vesting restrictions         69,529      
Exercise of stock options, shares         81,272      
Exercise of stock options 217         217    
Stock-based compensation expense 4,763         4,763    
Cumulative translation adjustment arising during the period $ (98)           (98)  
Temporary Equity Ending Balance, shares at Dec. 31, 2022 0              
Net loss $ (69,104)             (69,104)
Ending Balance at Dec. 31, 2022 179,631       $ 2 282,566 (81) (102,856)
Ending Balance, shares at Dec. 31, 2022         23,713,196      
Issuance of stock under the employee stock purchase plan $ 40         40    
Issuance of stock under the employee stock purchase plan, shares         9,694      
Exercise of stock options, shares 100,351       100,351      
Exercise of stock options $ 213         213    
Stock-based compensation expense 7,048         7,048    
Unrealized gain on marketable securities 11           11  
Cumulative translation adjustment arising during the period $ 104           104  
Temporary Equity Ending Balance, shares at Dec. 31, 2023 0              
Net loss $ (78,626)             (78,626)
Ending Balance at Dec. 31, 2023 $ 108,421       $ 2 $ 289,867 $ 34 $ (181,482)
Ending Balance, shares at Dec. 31, 2023         23,823,241